ITRAconazole Chew Treat
ITRAconazole is a compounded formulation containing ITRAconazole, prepared by Mixlab for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider itraconazole when a patient presents with dermatological conditions such as ringworm (dermatophytosis) or more severe systemic infections including blastomycosis, histoplasmosis and cryptococcosis. It is often a point of discussion for infections affecting the respiratory system, bone or skin where a high degree of lipophilicity—the ability to dissolve in fats—is required for the medication to reach the site of the pathogen.
At a pharmacological level, itraconazole acts by inhibiting the fungal enzyme cytochrome P450-dependent synthesis of ergosterol. Ergosterol is a vital component of the fungal cell membrane; by disrupting its production, the medication causes increased cellular permeability and inhibits fungal growth and replication. Because the absorption of certain formulations is highly dependent on an acidic environment, veterinarians typically discuss the administration of this medication alongside a meal. Your veterinarian will determine the appropriate application of itraconazole based on the species, the suspected fungal pathogen and the results of specific diagnostic testing.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects of itraconazole administration include gastrointestinal changes such as decreased appetite, vomiting or loose stools. Because the medication is processed by the liver, your veterinarian will monitor for shifts in hepatic enzymes, especially in patients with pre-existing liver concerns. In some cats, localized skin reactions or swelling have been noted as a metabolic result of therapy. Owners should watch for signs of jaundice, such as a yellowing of the skin or the whites of the eyes and contact their veterinarian promptly if these or persistent lethargy occur.This medication is typically used with extra caution or avoided in patients with known liver impairment or congestive heart failure, as it has been associated with negative inotropic effects in some species. Itraconazole is also carefully evaluated in breeding or pregnant animals due to potential risks to developing offspring. As a potent inhibitor of certain metabolic pathways, it is associated with a high number of interactions with other prescriptions, including certain sedatives, antacids and blood pressure medications. Before starting a protocol, ensure your veterinarian has a complete history of all other supplements and medications your pet is receiving. Your veterinarian is the right person to assess your pet's individual health status and provide guidance on the necessary duration of therapy to ensure the management approach remains suitable.
Yes. Itraconazole is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home.
Yes. While itraconazole is available in commercial capsules, Mixlab can compound this medication into specialized strengths or alternative flavored dosage forms—such as oral liquids or chews—if your veterinarian determines a customized preparation better suits your pet's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians typically recommend administering certain formulations of itraconazole with a meal because an acidic gastric environment can support better absorption into the bloodstream. If your pet has a decreased appetite, discuss alternative administration strategies with your veterinarian to ensure the medication remains appropriate.
Because this medication is processed by the liver and can involve a long duration of therapy, your veterinarian will likely recommend periodic blood work to monitor hepatic enzymes. These diagnostic follow-ups allow the veterinarian to ensure the management plan remains appropriate for your pet's individual health status.
